Search research articles
Contact Us
Filters
Showing results (101-110 of 107) with videos related to
Page
of 11
Sort By:
You have reached the last page of results.
This site can display upto 107 results.
Clinical Pharmacology and Therapeutics
|
May 22, 2020
Prioritization of Anti-SARS-Cov-2 Drug Repurposing Opportunities Based on Plasma and Target Site Concentrations Derived from their Established Human Pharmacokinetics
Usman Arshad, Henry Pertinez, Helen Box, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 9, 2020
Dose prediction for repurposing nitazoxanide in SARS-CoV-2 treatment or chemoprophylaxis
Rajith Kr Rajoli, Henry Pertinez, Usman Arshad, et al.
British Journal of Clinical Pharmacology
|
October 21, 2020
Dose prediction for repurposing nitazoxanide in SARS-CoV-2 treatment or chemoprophylaxis
Rajith K R Rajoli, Henry Pertinez, Usman Arshad, et al.
Nanoscale
|
October 24, 2024
Interlaboratory comparison of endotoxin contamination assessment of nanomaterials
Gary Hannon, Bethany J Heaton, Alexander Plant-Hately, et al.
The Journal of Experimental Medicine
|
January 12, 2011
Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection
Jens Wrammert, Dimitrios Koutsonanos, Gui-Mei Li, et al.
Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences
|
August 15, 2022
FAIR data pipeline: provenance-driven data management for traceable scientific workflows
Sonia Natalie Mitchell, Andrew Lahiff, Nathan Cummings, et al.
Gigascience
|
June 23, 2015
The ocean sampling day consortium
Anna Kopf, Mesude Bicak, Renzo Kottmann, et al.
Page
of 11
Search research articles
Search
Showing results (101-110 of 107) with videos related to
Sort By:
Page
of 11
You have reached the last page of results.
This site can display upto 107 results.
Clinical Pharmacology and Therapeutics
|
May 22, 2020
Prioritization of Anti-SARS-Cov-2 Drug Repurposing Opportunities Based on Plasma and Target Site Concentrations Derived from their Established Human Pharmacokinetics
Usman Arshad, Henry Pertinez, Helen Box, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 9, 2020
Dose prediction for repurposing nitazoxanide in SARS-CoV-2 treatment or chemoprophylaxis
Rajith Kr Rajoli, Henry Pertinez, Usman Arshad, et al.
British Journal of Clinical Pharmacology
|
October 21, 2020
Dose prediction for repurposing nitazoxanide in SARS-CoV-2 treatment or chemoprophylaxis
Rajith K R Rajoli, Henry Pertinez, Usman Arshad, et al.
Nanoscale
|
October 24, 2024
Interlaboratory comparison of endotoxin contamination assessment of nanomaterials
Gary Hannon, Bethany J Heaton, Alexander Plant-Hately, et al.
The Journal of Experimental Medicine
|
January 12, 2011
Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection
Jens Wrammert, Dimitrios Koutsonanos, Gui-Mei Li, et al.
Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences
|
August 15, 2022
FAIR data pipeline: provenance-driven data management for traceable scientific workflows
Sonia Natalie Mitchell, Andrew Lahiff, Nathan Cummings, et al.
Gigascience
|
June 23, 2015
The ocean sampling day consortium
Anna Kopf, Mesude Bicak, Renzo Kottmann, et al.
Page
of 11